INSPIRA PHARMACEUTICALS LIMITED - READING
Company Profile | Company Filings |
Overview
INSPIRA PHARMACEUTICALS LIMITED is a Private Limited Company from READING ENGLAND and has the status: Active.
INSPIRA PHARMACEUTICALS LIMITED was incorporated 3 years ago on 26/11/2020 and has the registered number: 13045376. The accounts status is TOTAL EXEMPTION FULL and accounts are next due on 31/08/2024.
INSPIRA PHARMACEUTICALS LIMITED was incorporated 3 years ago on 26/11/2020 and has the registered number: 13045376. The accounts status is TOTAL EXEMPTION FULL and accounts are next due on 31/08/2024.
INSPIRA PHARMACEUTICALS LIMITED - READING
This company is listed in the following categories:
46460 - Wholesale of pharmaceutical goods
46460 - Wholesale of pharmaceutical goods
Accounts Status
Accounting Year End (d/m) | Accounts Last Made Up Date | Accounts Next Due Date |
---|---|---|
30 / 11 | 30/11/2022 | 31/08/2024 |
Registered Office
OGMOOR HOUSE
READING
RG8 8ES
ENGLAND
This Company Originates in : United Kingdom
Confirmation Statements
Last Statement | Next Statement Due |
---|---|
16/04/2023 | 30/04/2024 |
Map
ENGLAND
Company Officers - Current and Previous
Name | Born | Nationality | Role | Appointed | Status |
---|---|---|---|---|---|
MR RORY JAMES MCGOLDRICK | Aug 1980 | Australian | Director | 2021-01-11 | CURRENT |
JESSICA ELIZABETH JACKSON | Jun 1986 | British | Director | 2021-08-15 | CURRENT |
MR NICHOLAS LESLIE WOOLF | Jul 1968 | British | Director | 2020-11-26 UNTIL 2023-11-14 | RESIGNED |
Persons with Significant Control
Name | Active from | Born | Address | Level of control |
---|---|---|---|---|
Mr Rory James Mcgoldrick | 2023-09-18 | 8/1980 | Reading | Ownership of shares 25 to 50 percent |
Mr Nicholas Leslie Woolf | 2020-11-26 - 2023-07-12 | 7/1968 | Reading | Significant influence or control |
Free Reports Available
Report | Date Filed | Date of Report | Assets |
---|---|---|---|
Inspira Pharmaceuticals Limited - Accounts to registrar (filleted) - small 23.2.5 | 2024-05-11 | 30-11-2023 | £12,353 Cash £38,167 equity |